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A rapid throughput screening system involving gene expression analysis was developed in order to
investigate the potential of bioactive chemicals contained in natural health products as effective drug
therapy, in particular the ability of these chemicals to alleviate the inflammatory response in human air-
way epithelial cells. A number of databases were searched to retrieve the information needed to properly
analyze the gene expression profiles obtained. The gene expression of human bronchial epithelial cells
infected with rhinovirus and/or exposed to platelet activating factor was analyzed. Following analysis of
the gene expression data the total number of expressed proteins that may potentially act as a marker for
monitoring the modulation of airway inflammation was narrowed to 19. Further studies will involve
selecting antibodies for these proteins, culturing airway epithelial cells in the presence of extracts of nat-
ural health products, extracting the proteins and identifying them by western blot analysis.
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Introduction
Airway inflammation is a feature of lung diseases and is char-
acterized by airway swelling, excessive airway secretions,
cellular infiltration and increased airway responsiveness (1).
These diseases include asthma, chronic obstructive pulmonary
diseases, chronic bronchitis, bronchiectasis and cystic fibrosis.
Herbal medicinal products are composed of bioactive chemic-
als, some of which may have therapeutic usefulness and some
which may be toxic (2). For example, echinacea preparations
contain many potentially active ingredients, such as polysac-
charides, glycoproteins, alkamides and flavonoids (3). This
herbal medicine has been traditionally used for the treatment
and prevention of upper respiratory tract infections and is usu-
ally marketed as an immune system booster (4). However, as
with many other natural health products, much confusion
exists concerning the therapeutic potential and pharmacolo-
gical properties of echinacea.
As a result of the increased popularity of natural health
products, herbal medicinal products, such as echinacea, are
being used more and more to treat the symptoms of airway
inflammatory diseases. However, the effects of these products
on the inflammatory pathway have yet to be elucidated and the
efficacy of these products in treating airway inflammation is
still debatable. The development of microarray technology
and gene expression analysis has proved to be a valuable tool
in drug discovery and in understanding the molecular basis
of human disease. By comparing the gene expression patterns
of healthy airway tissue with airway tissue undergoing inflam-
mation, it is possible to elucidate the genetic basis of airway
inflammation and establish a means by which herbal medicinal
products can be evaluated as to their effects on the inflammat-
ory pathway.
The purpose of this study was to develop a rapid throughput
screening system to investigate the potential of the bioactive
chemicals contained in natural health products as effective
drug therapy. Of particular interest is the ability of these
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airway epithelial cells.
Methods
Cell Culture
The 16HBE14o- cell line, immortalized from primary cultures
of nasal polyp epithelial cells using the SV40 gene (5), was a
gift from Dr D. C. Gruenert (University of California, San
Francisco). CFNPE9o  cells were maintained in minimum
essential medium (MEM; Gibco BRL, Gaithersburg, MD)
with 10 % fetal bovine serum (Gibco BRL) at pH 7.4 under a
humidified atmosphere of 5% CO2 (balance air) at 37 C. Cells
were passaged every 4–5 days (at confluence) by exposure to
0.1% trypsin in phosphate buffered saline (PBS) for 5 min,
after which the cells were dislodged from the culture dish by
gentle agitation and collected by centrifugation at 800 g for
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Figure 1. AffymetrixGeneChip expression analysis.
66 Potential of bioactive chemicals contained in natural health products5 min. PBS consisted of (mM): NaCl (137), KCl (2.7),
Na2HPO4 (15.2) and KH2PO4 (1.5), pH 7.4. Pelleted cells
were then resuspended in MEM at 5 · 10
6 cells ml
 1, and pla-
ted at a density of 5 · 10
5 cells cm
 2 in 60 mm plastic culture
dishes (Falcon, Becton Dickson and Co., Lincoln Park, NJ).
Drug Treatment
Platelet Activating Factor (PAF) was obtained from Sigma
Chemical Co., dissolved in ethanol and diluted to the desired
concentration with MEM (final ethanol concentration
was <0.01%). Cells were grown to confluence (usually 3–
4 days) and treated with 10 mM PAF for 12 h. Non-PAF treated
cells contained 0.01% ethanol to control for any potential eth-
anol effect. Cells infected with rhinovirus were incubated for
24 h in medium containing rhinovirus 14 (obtained from
ATCC, Manassas, VA) at a viral concentration of 100 plaque
forming units (PFUs)/ml. All incubations were conducted at
37 C.
RNA Extraction
Total RNA was extracted with the RNeasy  Mini Kit (Qiagen
Inc., Mississauga, ON). Briefly, upon termination of the
incubation period, cells were washed twice with PBS at 4 C,
followed by exposure to 600 ml Buffer RLT at 4 C for 5 min.
Lysate was collected using a rubber policeman and transferred
under RNase-free conditions to a collection tube and homo-
genized for 30 seconds using a Polytron fitted with a small vol-
ume rotor-stator. The homogenate was mixed with an equal
volume of 70% ethanol and thoroughly mixed by trituration.
Of the mixture, 700 ml was applied to an RNeasy mini column
and centrifuged at 9000 g for 15 s. The column was washed by
adding 700 ml of Buffer RW1 and centrifuging as before. The
mini column was transferred to a new collection tube and dried
by application of 500 ml of Buffer RPE. The mini column was
centrifuged as before and the drying procedure was repeated.
Finally, the mini column was transferred to a fresh collection
tube and the RNA was eluted twice with RNase-free water
(50 ml) and centrifugation as above.
Gene Microarray
Microarray analysis was performed using the Affymetrix
(Santa Clara, CA) HG-U133 A and B Human genome
GeneChip  sets (containing probes for over 33 000 human
genes) as described in the standard protocol outlined in the
GeneChip  Expression Analysis Technical Manual (Affymet-
rix). Each experimental sample RNA was processed and run on
separate HG-U133 chip sets. Briefly, cDNA was synthesized
using T7-(dt)24 oligos and SuperScript II RT (Invitrogen,
Carlsbad, CA) followed by T4 Polymerase and was purified
using Phase Lock Gel (Promega Corp., Madison, WI) and
phenol: chloroform extraction. Labeling was carried out using
biotinylated CTP in an in vitro transcription reaction. The
resulting labeled cRNA was then fragmented according to
Affymetrix protocols and added to the recommended hybrid-
ization mixture. Approximately 10 mg of cRNA was used per
Affymetrix U-133 GeneChip A and B  sets. Hybridization
and washing were carried out in accordance with Affymetrix’s
established protocols. The probe array was scanned using an
Affymetrix confocal laser scanner. The scanner generated an
image of the array by exciting each feature with its laser,
detecting the resulting photon emissions from the fluorescently
labeled cRNA that had hybridized to the probes, and convert-
ing the detected photon emissions into a 16-bit intensity value
(6,7). The amount of light emitted at 570 nm was proportional
to the bound target at each location on the probe array (8).
The probe array images generated by the scanner were then
ready for analysis using the Affymetrix Microarray Suite
software.
The use of microarray technology to monitor gene expres-
sion in cell lines and human tissues has become an important
part of biological research. It allows for the analysis of bio-
chemical pathways, the identification of the genes responsible
for a particular phenotype and the assessment of the effect
of a compound on the expression level of a large number of
genes (6). The Affymetrix Microarray Suite software per-
formed the operations necessary to process and analyze the
probe array, including: image segmentation, background
correction, scaling/normalizing arrays for array-to-array com-
parisons, calculation of statistics to indicate whether a gene
transcript was present, and calculation of statistics to indicate
whether a gene transcript was differentially expressed (6).
The results of the analysis provided a list of genes that showed
at least a 2-fold expression (upregulated and downregulated)
compared with controls.
Online bioinformatic databases were used to analyze the
results of the gene expression data. Proteomic databases were
searched to determine the functions of the proteins coded by
the expressed genes. Once these proteins were identified and
studied, a set was chosen to be indicators for changes in airway
inflammation. The purpose of these indicator proteins is to
identify which bioactive compounds affect the inflammation
process. Bioactive compounds with anti-inflammatory activit-
ies would be able to prevent the upregulated or downregulated
expression of the indicator proteins which are otherwise
expressed under conditions of airway inflammation, when the
bioactive compound is not present. The ultimate objective
was to determine which bioactive compounds of natural health
products are effective in alleviating the airway inflammatory
Table 1. Proteomic databases utilized
Ensembl http://www.ensembl.org
Source database http://source.stanford.edu
Online Mendelian
Inheritance in Man (OMIM)
http://http://www.ncbi.nlm.nih.gov/
entrez/query.fcgi?dp=OMIM
National Center for
Biotechnology Information
http://www.ncbi.nlm.nih.gov
European Bioinformatic Institute http://www.ebi.ac.uk
SwissProt database http://www.expasy.org/sprot/
Gene Ontology Consortium http://www.geneontology.org/
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eases and conditions.
Results
Human bronchial epithelial cells were infected with rhinovirus
and/or exposed to PAF, producing three experimental groups:
PAF and no virus, virus and no PAF, and both virus and
PAF. The control group was made up of cells with neither virus
nor PAF. Three plates were grown for each of the three experi-
mental groups and four plates were grown for the control
group, giving a total of 13 samples analyzed with the Affymet-
rix GeneChip HG U133A microarray. The results from the
four samples of controls showed an average of 43.7% of the
probe sets evaluated as being present.
Following analysis of the gene expression data using proteo-
mic databases, the genes of interest were narrowed down to
19. These were TRIM15, HPGD, C1orf38, VNN2, IL-8,
STAT1, CXCL10, LGALS3BP, TNFSF10, TNFRSF6, CCR1,
OASL, HLA-B, HLA-G, HLA-DPA1, PLAUR, C3, BTN3A3
and GPR37. In particular, TRIM15, HPGD, C1orf38 and
VNN2 were of interest because they were upregulated in both
thevirusvs.controlsandPAFvs.controls.Thefollowingisades-
cription of some of these genes which are of particular interest.
IL-8 (Interleukin 8) is of interest as the protein coded by this
gene is a chemokine, one of the major mediators of the inflam-
matory response. This gene is believed to play a role in the
pathogenesis of bronchiolitis, a common respiratory tract dis-
ease caused by viral infection (9).
CXCL10 [Chemokine (C-X-C motif) Ligand 10] encodes a
chemokine that is one of the ligands for CXCR3. The binding
of this protein to CXCR3 causes pleiotropic effects, including
stimulation of monocytes, natural killer and T-cell migration,
and modulation of adhesion molecule expression (9).
CCR1 [Chemokine (C-C motif) Receptor 1] encodes a
member of the beta chemokine receptor family. The ligands
of this receptor include macrophage inflammatory protein 1
alpha (MIP-1 alpha), monocyte chemoattractant protein 3
(MCP-3) and myeloid progenitor inhibitory factor-1 (MPIF-
1). Chemokines and their receptors are critical for the recruit-
ment of effector immune cells to the site of inflammation (9).
C3 (Complement Component 3) plays a central role in the
activation for both the classical and alternative complement
activation pathways. Individuals with C3 deficiency are
susceptible to bacterial infections (9).
Discussion
The development of DNA microarray assays has provided the
possibility of studying inflammatory responses from a totally
new viewpoint. Previous gene expression studies conducted
on airway epithelial cells have focused on a single inflammat-
ory agent, assuming that the cellular responses would be
uniform and standard (10–14). However, it is now possible to
take a global view of the inflammatory process by looking
for changes in gene expression, without necessarily knowing
the precise function of the genes showing altered expression
[(15), this study]. Two intriguing possibilities arise from this
approach. First, previously unsuspected genes can be identi-
fied as playing a role in the cellular inflammatory responses.
Second, it provides the possibility to develop a rapid assay
for assessing anti-inflammatory activity of biologically active
compounds, including naturally derived products. By identify-
ing a panel of 40–50 proteins that consistently show changes in
expression, we can develop a western-blot based quantitative
assay. Initial identification of candidate proteins is far quicker
using DNA microarray techniques.
Our previous work on the variability in [Ca
2þ]i signaling
strongly implies that there are different inflammatory res-
ponses mounted by airway epithelial cells. These responses
can be very short-lived [as seen with bradykinin stimulation;
(16,17)], have a moderate duration [as seen with histamine
stimulation; (17,18)], or be much longer lived [as seen
with ATP stimulation; (19,20)]. PAF (maximal concentration
10 mM) stimulates a markedly different change in [Ca
2þ]i.
Rather than a rapid rise, [Ca
2þ]i increases relatively slowly
over the first 2–3 min of exposure, reaching a plateau which
persists for the duration of exposure to PAF (Harris, unpub-
lished data). The magnitude of this plateau is comparable
with the peak elicited during stimulation with ATP (17–19),
BK (16,17) or histamine [>1500 mM; (17,18)] and is main-
tained for long duration, making it an ideal choice to provoke
the inflammatory response. Furthermore, there is a growing
body of evidence suggesting that PAF plays a significant role
in mediating airway inflammation (21–28). In this study, our
focus was on the long-term cellular inflammatory responses
involving changes in gene expression. These are the types
of inflammation which would be provoked during a viral
infection, such as rhinovirus or influenza (29,30).
Bioinformatics is commonly referred to as the task of
organizing and analyzing complex data resulting from modern
molecular and biochemical techniques (31). Computers make
it possible to manage this increasing amount of data. In addi-
tion, the advent of the Internet has allowed for the fast and
free flow of information. It has become a vital tool for scient-
ists because it allows for the sharing of information contained
in centralized databases.
A numberof databaseswere searchedto retrieve the informa-
tion needed to properly analyze the gene expression profiles
obtained from the Affymetrix Microarray Suite Software.
Information was obtained for the expressed genes from four
comparison groups: virus vs. controls increases, virus vs. con-
trolsdecreases, PAFvs.controlsincreasesandPAFvs. controls
decreases. The Affymetrix Probe Set ID codes, which represent
the expressed genes from the Affymetrix microarray analysis,
were deciphered using the Ensembl database. The Ensembl ser-
ver produces and maintains an automatic annotation database
oneukaryotic genomes.Itistheresultofajointprojectbetween
the European Bioinformatics Institute (EBI) and the Sanger
Institute. Ensembl is capable of automatically tracking gene
sequences of the human genome and assembling and analyzing
them to identify genes and other features of interest (32). For
68 Potential of bioactive chemicals contained in natural health productsthis study, Ensembl was able to correspond the gene name with
the Affymetrix code.
Once the gene names were known, other databases could
then be searched for additional information about the genes.
One useful database was the Source database. Its main advant-
age is its user-friendly interface and that it combined data
from many data sources. The Source database brings together
information from a broad range of resources and provides
it in a manner particularly useful for analyses. Source’s
GeneReports include gene aliases, chromosomal location,
functional descriptions, GeneOntology annotations, gene
expression data and links to external databases. Biological
roles and summary of functions are based on information
from the LocusLink database and the SwissProt database.
GeneOntology annotations provide information on the bio-
logical process, molecular function and cellular component
of the protein. In addition, the Source database provides links
to outside databases containing gene information ranging
from their mapped coordinates within the genome to enzym-
atic function of the proteins they code for. These linked data-
bases include Online Mendelian Inheritance in Man (OMIM),
LocusLink, UniGene, GenAtlas, GeneCard, and Ensembl. A
useful feature of the source database is its ability to extract
data for a batch set of genes; thereby allowing for the efficient
retrieval of information for many genes at once. A batch search
is done using either the gene’s clone ID, accession number,
gene name, gene symbol, UniGene ID, or LocusLink ID.
These are then uploaded to the server via a text file. Since
many of the resources on which the database is based are fre-
quently updated, the Source database is re-loaded on a weekly
basis to ensure that it contains the most up-to-date information
(33). In order to aid analysis, the genes were organized accord-
ing to biological process and molecular function based on the
GeneOntology annotations. GeneOntology annotations are
organized by the Gene Ontology Consortium, which provides
consistent descriptions of gene products in different databases.
The OMIM database was used to obtain a more detailed
summary of the expressed genes. OMIM is a comprehensive
knowledge base of human genes and genetic disorders com-
piled to support research and education in human genomics.
It is considered to be a phenotypic companion to the human
genome project. OMIM is written and edited at Johns Hopkins
University with input from scientists and physicians around the
world (34). It was started by Dr Victor A. McKusick and is
available on the Internet via the National Center for Biotech-
nology Information (NCBI). The NCBI, along with the
European Bioinformatic Institute (EBI), provides many of
the bioinformatic tools and databases available on the Internet.
The OMIM database can be searched by MIM number, dis-
order, gene name or gene symbol. The limits function may
be used to perform a restricted search. Each OMIM entry has
a full-text summary of a gene with links to literature refer-
ences, sequence records, gene location and related databases.
Links to literature references throughout the gene summary
are particularly useful in providing further detail of the
information presented.
Viral infections have many effects on the airways including
potentiation of the airway response to tachykinins, an increase
in vagally mediated reflex bronchoconstriction, and the
recruitment and activation of inflammatory cells (1). In direct
response to viral products, airway epithelial cells can initiate
inflammatory cascades by generating cytokines (35). Airway
epithelial cell responses to inflammatory mediators can also
invoke local cytokine networks by initiating synthesis and
release of interleukins, chemokines, colony stimulating factors
and growth factors (5). Cytokines communicate in a paracrine
manner with infiltrating inflammatory cells and airway cells
(1). Inflammation is a localized protective response, which
can be induced by microbial infection; therefore, upregulation
of genes that have an antimicrobial function or are involved in
the immune response is probable (35). Inflammation is also
associated with excessive airway secretions, which may
involve the upregulation of receptors (1). In addition, a number
of pathways involving cAMP and protein kinase may be activ-
ated during an inflammatory response.
The initiation of the inflammatory response resulted in
changes in human bronchial epithelial cell gene expression
which were monitored using Affymetrix GeneChip probe
arrays. Once all the information was compiled and analyzed,
the next step was to choose a set of proteins to serve as indic-
ators for changes in airway inflammation. Genes of interest
were those that function as receptors, cytokines, interleukins,
antimicrobials and were involved in either the inflammatory
response, immune response, transport processes or protein
kinase pathways. Cytokines and interleukins were of interest
because they are synthesized and secreted by airway epithelial
cells during the inflammatory response.
After completing analysis of the gene expression data, the
total number of expressed proteins that may potentially act as
a marker for monitoring the modulation of airway inflammation
was narrowed to 19. Further studies will involve selecting anti-
bodies for these proteins, culturing airway epithelial cells in the
presence of extracts of natural health products, extracting the
proteins and identifying them via western blot electrophoresis.
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